Tezspire

Tezspire is a medicine authorised by Swissmedic under authorisation number 68454. The authorisation holder is AstraZeneca AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 June 2022 and the authorisation is valid without a time limit. ATC code R03DX11 places the medicine in the group Drugs for obstructive airway diseases.

  • Dispensing category B
  • Authorisation number 68454
  • ATC R03DX11
  • Biotechnological medicines
Authorisation data
Authorisation number68454
NameTezspire
Full nameTezspire, Injektionslösung in einer Fertigspritze
Authorisation holderAstraZeneca AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeR03DX11
First authorisation13 June 2022
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Tezspire, Injektionslösung in einer FertigspritzeB13 June 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Fertigspritze(n)R03DX1103.04.5.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Tezspire authorised in Switzerland?

Yes. Tezspire is authorised by Swissmedic under authorisation number 68454, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Tezspire have?

Tezspire is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Tezspire?

The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com